As tax dollars ultimately pay for most of these drugs, we continue to ask Gilead to show even a modicum of restraint in its drug pricing, particularly for programs such as Medicaid, Medicare, private insurers and other payors.??? Gilead has long been one of the most profitable pharmaceutical companies and produces many of the most widely prescribed HIV/AIDS drugs.